Brief: Oncopeptides Sees Q2 Sales At SEK 19.2 Mln

Oncopeptides AB

09/07/2025 10:52

July 9 (Reuters) - Oncopeptides AB ONCO.ST:

Q2 SALES SEK 19.2 MILLION

EXPECTS NET SALES FOR Q2 TO AMOUNT TO SEK 19.2 MILLION (SEK 8.2 MILLION FOR Q2 2024)

STRONGER-THAN-EXPECTED ORGANIC SALES GROWTH IN GERMANY

FASTER-THAN-EXPECTED MARKET ACCESS IN SPAIN AND ITALY

EXPECTS GROWTH MOMENTUM TO CONTINUE INTO H2, WITH COST BASE EXPECTED TO REMAIN AT A STABLE LEVEL

Source text: ID:nMFN6mKnCn

Further company coverage: ONCO.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))